Clinical Trials Browser

Phase 2 × Eflornithine × Dermatologic × Clear all

NCT00204789 2019-12-16

Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients

Phase 2 Completed

Skin Neoplasms

NCT00021294 2018-09-11

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

Phase 2 Completed

DermatologicOther neoplasm

Carcinoma, Basal Cell, Precancerous Conditions, Keratosis, Actinic